Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.28 USD | +2.90% | -0.08% | -13.60% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.60% | 466M | |
+9.48% | 115B | |
+12.84% | 107B | |
-13.73% | 22.31B | |
-3.46% | 21.6B | |
-4.84% | 18.23B | |
-38.57% | 17.62B | |
+7.25% | 14.26B | |
+34.95% | 12.37B | |
-26.21% | 8.28B |
- Stock Market
- Equities
- URGN Stock
- News UroGen Pharma Ltd.
- Transcript : UroGen Pharma Ltd., Q1 2022 Earnings Call, May 10, 2022